[Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
Drugs used in the management of peptic ulcer are reviewed with special attention to the possibilities offered by H2 receptor antagonists. In this context, histaminergic transmission and distribution of H2 receptors are briefly reviewed. Among other substances, special interest has been raised by H+ and K+-dependent ATPase inhibitors; the most recently introduced derivatives of these substances which are as yet in the experimental stage, are also listed.
De Natale
G
G
De Natale
F
F
Marino
A
A
D000863:Antacids / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D002927:Cimetidine / Q000627:therapeutic use; D015738:Famotidine; D005260:Female; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009853:Omeprazole / Q000627:therapeutic use; D010437:Peptic Ulcer / Q000188:drug therapy*; D010890:Pirenzepine / Q000627:therapeutic use; D011899:Ranitidine / Q000627:therapeutic use; D013844:Thiazoles / Q000627:therapeutic use
D000863:Antacids; D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D013844:Thiazoles; D010890:Pirenzepine; D015738:Famotidine; D002927:Cimetidine; D011899:Ranitidine; D009853:Omeprazole
Farmaci impiegati nella terapia dell'ulcera peptica con particolare riferimento agli anti-H2.